New Publication: Reaksi Drug Safety News - Issue 3/2017 Cetak Kadar pengguna: 1 / 5 Sila beri kadar Undi 1 Undi 2 Undi 3 Undi 4 Undi 5 REAKSI Drug Safety News, Issue 3/2017 Loperamide: Risk of Serious Cardiac Adverse Events with High Doses, Including Through Misuse Thalidomide, Lenalidomide and Pomalidomide: Risk of Hepatitis B Reactivation, Herpes Zoster and Pulmonary Hypertension DOWNLOAD PDF